AI-powered care coordination platform for disease detection and workflow optimization, powered by 50+ FDA-cleared AI algorithms. Trusted by over 2,000 hospitals.
AI-powered care coordination platform for disease detection and workflow optimization, powered by 50+ FDA-cleared AI algorithms. Trusted by over 2,000 hospitals.
AI-powered suite of solutions designed to accelerate patient diagnosis and treatment, enabling radiologists to optimize their time for informed decisions and recommendations.
Proprietary communication and workflow tool that unites multidisciplinary specialists and care teams across therapeutic areas to direct more patients to faster follow-ups.
Providers Viz.ai One Viz One: Enterprise Platform Viz Assist Viz Assist: Workflow Assistant Viz Neuro Suite Cerebral Aneurysm CT Perfusion (CTP) Hemorrhage Hyperdensity Measurements Large Vessel Occlusion (LVO) Post…
Viz.ai to Support the MINUTE Trial for Intracerebral Hemorrhage Treatment
Viz.ai announced it will provide its Viz Neuro Suite, including Viz ICH and Viz ICH Plus, to support the multicenter MINUTE trial. The study evaluates the SCUBA technique—an endoscopic, catheter-based approach for the evacuation of basal ganglia intracerebral hemorrhage. Viz.ai's platform will be used at participating trial sites to facilitate rapid patient identification and care coordination, aiming to assist clinical teams in meeting the study's ultra-early intervention protocol of within 120 minutes of key clinical time points.
MentionedNewYork-Presbyterian/Weill Cornell Medical CenterMentionedWeill Cornell MedicineMentionedMedical University of South CarolinaMentionedBeth Israel Deaconess Medical CenterMentionedUniversity of Cincinnati
Partnership
Viz.ai Partners with Cortechs.ai to Expand into Neurodegenerative Disease
Viz.ai has entered a partnership with Cortechs.ai to integrate NeuroQuant and NeuroQuant MS software into the Viz platform. This initiative marks Viz.ai’s formal expansion into neurodegenerative disease, beginning with multiple sclerosis (MS) care. By incorporating quantitative MRI analysis directly into its care coordination workflow, the company aims to help clinicians improve the identification and management of patients with MS and other neurodegenerative conditions across its U.S. hospital network.
